Adverts

Open Access Articles- Top Results for Idalopirdine

Idalopirdine

</th></tr>
Idalopirdine
File:Lu-AE58054.svg
Systematic (IUPAC) name
2-(6-Fluoro-1H-indol-3-yl)-N-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)ethanamine
Clinical data
Identifiers
467459-31-0 7pxN
None
ChemSpider 19878969 7pxN
Synonyms Lu-AE-58054
Chemical data
Formula C20H19F5N2O
398.37 g/mol
 14pxN (what is this?)  (verify)

Idalopirdine (INN) (code names Lu AE58054, SGS-518) is a potent and selective 5-HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated with Alzheimer's disease and schizophrenia.[1][2] As of October 2013 it is in phase III clinical trials.[2]

See also

References

External links